Tilray Brands (TLRY) Stock Price, Quote, News & History

Tilray Brands Inc (TLRY) Stock Price, Quote, News & History

TLRYNASDAQ

Trade with Public

$6.90

0.010.15%

At close: Mar 13, 5:00 PM EST

$6.88

-0.006-0.09%

Pre-Market: 8:04 AM EST

M&A: BrewDog announced it will sell assets to Tilray Brands (TLRY) on Monday, March 16, 2026

Key Statistics

Open

$6.90

Volume / Avg.

7.98K / 6.84M

Day Range

- - -

52 Wk Range

3.51 - 23.20

Market Cap

$802.03M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

14.41%

Days to Cover

7.57

Recent Tilray Brands Inc News

PRO
Tilray Brands Enters Into Asset Purchase Agreement To Acquire Certain Strategic Assets Of BrewDog In US; Terms Not Disclosed

Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis, and wellness industries,

Benzinga Newsdesk

PRO
Tilray Expands Drug and Medical Cannabis Distribution Through Major German Pharmacy Network

Tilray Pharma, the pharmaceutical division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced a strategic partnership with Tilray Medical, CC Pharma, 14U Pharma, and "gesund leben" cooperation, which is

Benzinga Newsdesk

Tilray Taps Light Beer Market With New 'Pub Light' Launch

Tilray (TLRY) shares rise premarket as the company launches Pub Light beer and expands its global beverage portfolio. Get the latest details.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-28.45M

Investing Cash Flow (TTM)

-20.14M

Financing Cash Flow (TTM)

102.66M

Free Cash Flow (TTM)

-68.41M

Capital Expenditure (TTM)

-39.96M

Net Change in Cash (TTM)

54.08M

Analyst Trends and Forecast

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$831.98M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.83

PB Ratio (TTM)

0.51

Earnings Yield % (TTM)

-341.01%

Earnings Yield % (FWD)

-2.45%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$13.56

Company Debt

Total Debt

$250.45M

LT Debt

$224.99M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$15.16M

Total Cash

$246.70M

Debt to Equity

0.20

Issuance of Debt (TTM)

-$11.71M

Repayment of Debt (TTM)

-$14.88M

Key Statistics

Open

$6.90

Volume / Avg.

7.98K / 6.84M

Day Range

- - -

52 Wk Range

3.51 - 23.20

Market Cap

$802.03M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

14.41%

Days to Cover

7.57

About

Sector

Health Care

Industry

Pharmaceuticals

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medic...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tilray Brands (TLRY) stock?

You can purchase shares of Tilray Brands (NASDAQ:TLRY) through any online brokerage.

View our list of the best stock brokerages

Who are Tilray Brands (TLRY) competitors?

Other companies in Tilray Brands’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), Zevra Therapeutics Inc (NASDAQ:ZVRA), GH Research PLC (NASDAQ:GHRS), Bioage Labs Inc (NASDAQ:BIOA) and Xeris Biopharma Holdings Inc (NASDAQ:XERS).

What is the forecast, or price target, for Tilray Brands (TLRY) stock?

Tilray Brands has a consensus price target of $3.63.

What is the current price for Tilray Brands (TLRY)?

The stock price for Tilray Brands (NASDAQ: TLRY) is $6.884 last updated March 17, 2026 at 8:07 AM EDT.

Does Tilray Brands (TLRY) pay a dividend?

There are no upcoming dividends for Tilray Brands.

When is Tilray Brands (NASDAQ:TLRY) reporting earnings?

Tilray Brands does not have any upcoming earnings scheduled.

Is Tilray Brands (TLRY) going to split?

There is no upcoming split for Tilray Brands.

What sector and industry does Tilray Brands (TLRY) operate in?

Tilray Brands is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Theravance Biopharma Inc

NASDAQ:TBPH

$13.93

Zevra Therapeutics Inc

Xeris Biopharma Holdings Inc

NASDAQ:XERS

$5.45

-0.73%

Phathom Pharmaceuticals Inc

NASDAQ:PHAT

$10.47

0.29%

Aquestive Therapeutics Inc

NASDAQ:AQST

$4.18

Esperion Therapeutics Inc

NASDAQ:ESPR

$2.71

0.64%

Key Statistics

Open

$6.90

Volume / Avg.

7.98K / 6.84M

Day Range

- - -

52 Wk Range

3.51 - 23.20

Market Cap

$802.03M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

14.41%

Days to Cover

7.57

Recent Tilray Brands Inc News

PRO
Tilray Brands Enters Into Asset Purchase Agreement To Acquire Certain Strategic Assets Of BrewDog In US; Terms Not Disclosed

Benzinga Newsdesk

PRO
Tilray Expands Drug and Medical Cannabis Distribution Through Major German Pharmacy Network

Benzinga Newsdesk

Tilray Taps Light Beer Market With New 'Pub Light' Launch

Tilray (TLRY) shares rise premarket as the company launches Pub Light beer and expands its global beverage portfolio. Get the latest details.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-28.45M

Investing Cash Flow (TTM)

-20.14M

Financing Cash Flow (TTM)

102.66M

Free Cash Flow (TTM)

-68.41M

Capital Expenditure (TTM)

-39.96M

Net Change in Cash (TTM)

54.08M

Analyst Trends and Forecast

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$831.98M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.83

PB Ratio (TTM)

0.51

Earnings Yield % (TTM)

-341.01%

Earnings Yield % (FWD)

-2.45%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$13.56

Company Debt

Total Debt

$250.45M

LT Debt

$224.99M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$15.16M

Total Cash

$246.70M

Debt to Equity

0.20

Issuance of Debt (TTM)

-$11.71M

Repayment of Debt (TTM)

-$14.88M

Key Statistics

Open

$6.90

Volume / Avg.

7.98K / 6.84M

Day Range

- - -

52 Wk Range

3.51 - 23.20

Market Cap

$802.03M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

14.41%

Days to Cover

7.57

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry